http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112012007091-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24d41624f4c12622605b7048517fe8f7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2010-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f69e77c7def90721614bd0ef14a8ca5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ff482bd1353861f39b3d1a5a109464f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c237cbc257588b09170f5840602e99b
publicationDate 2016-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112012007091-A2
titleOfInvention olopatadine compositions and their uses
abstract olopatadine compositions and their uses. The present invention relates to olopatadine-containing solution compositions and a pde4 inhibitor compound of formula I: The invention also provides methods for treating allergic and inflammatory diseases. more specifically, the present invention relates to olopatadine formulations and their use to treat and / or prevent allergic or inflammatory eye, nose, skin and ear disorders.
priorityDate 2009-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281071

Total number of triples: 32.